VaxTRIALS, a Clinical Research Organization (CRO) now part of the Emmes Group, has been a major force in advancing vaccine research, particularly in Latin America. Its achievements include:
- Leading the fight against Polio: VaxTRIALS played a key role in the development of nOPV2, a vaccine that now protects children in more than 35 countries.
- Driving vaccine development in Latin America: Its successful clinical trials, with more than 8,000 participants enrolled, have directly contributed to the development and deployment of effective vaccines in the region.
These achievements are just some of the reasons VaxTRIALS has been recognized as a Fierce CRO award winner. This prestigious award honors its pioneering work in accelerating vaccine development.
We are proud to collaborate with Emmes Group. Leveraging our advanced E-diary and adverse event (AE) tracking technology, we have worked together to streamline vaccine clinical trials and provide high-quality data.
Our commitment to global health remains unwavering. Want to learn more about how our innovative technology is shaping the future of vaccine research?
Explore our success story here:
